MedTrace Logo

Turmeric and Exercise-Induced Muscle Damage and Oxinflammation

NCT04765527 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2021-06-21

No results posted yet for this study

Summary

The purpose of this study is to measure the effect of using a turmeric-based supplement for 2-weeks on muscle damage and soreness that occur in the body after 90-minutes of exercise. Participants will first come to the human performance lab (HPL) for orientation and pre-study fitness tests including muscular fitness and body composition. Participants will be randomized to turmeric or placebo groups, and take 2 tablets of the supplements each day for the first two weeks. Participants will report back to the HPL on a Monday to engage in weight lifting and calisthenics for 90 minutes. Fitness tests (vertical jump, bench press, leg-back lift for strength, 30-second cycling sprint test) and blood samples will be given and collected before and after this exercise session. Participants will then come back to the HPL each morning, Tuesday through Friday, in the early morning to provide blood samples and retake the fitness tests. This study will entail seven HPL visits over a 3-week period.

Conditions

  • Muscular Injury

Interventions

DIETARY_SUPPLEMENT

Turmeric Strength for Joint

Turmeric-based tablets

DIETARY_SUPPLEMENT

Placebo

Placebo tablets

Sponsors & Collaborators

  • MegaFood

    collaborator UNKNOWN

  • Appalachian State University

    lead OTHER

Principal Investigators

  • David C Nieman, DrPH · Appalachian State Univ

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-15
Primary Completion
2021-06-15
Completion
2021-06-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04765527 on ClinicalTrials.gov